Furthermore, it showed that only patients with FAT1 variants had CRC, and most patients harboured variants in genes such as CHEK2, ERBB2, and KIT in most of the cancers (Supplementary Fig. 4c). This evidence concerns the gene CHEK2 and colorectal carcinoma.